Publications by authors named "Bas Calcoen"

Claim this Profile
A
A novel p.C1130S mutation in a Finnish family with a complex phenotype of von Willebrand disease.
Bas Calcoen, Irina Portier, Inge Pareyn, Aline Vandenbulcke, Anna-Elina Lehtinen

Haematologica· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementarity determining regions in SARS-CoV-2 hybrid immunity.
Glynis Frans, Doreen Dillaerts, Tom Dehaemers, Jan Van Elslande, Jonas De Leeuw, Bas Calcoen

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model.
Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen

iScience· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.
Bas Calcoen, Nico Callewaert, Aline Vandenbulcke, Winnie Kerstens, Maya Imbrechts

Viruses· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The concentration of GPIbα magnetic particles is a critical parameter occasionally responsible for poor reproducibility of the VWF:GPIbR chemiluminescent immunoassay.
Bas Calcoen, Isa Van Horenbeeck, Mirjam Debasse, Jelle Toelen, Ingrid Vanlinthout

Int J Lab Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An abrupt rise of coagulation error messages on ACL TOP automated analysers.
Bas Calcoen, Koen Desmet, Pieter Vermeersch

Biochem Med (Zagreb)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients.
Sam Van Hecke, Bas Calcoen, Katrien Lagrou, Johan Maertens

Future Microbiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis